Temat: "Gout Suppressants" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Prescribing cascades of antigout medications from thiazide diuretics in gout-naïve hypertensive adults receiving first-line pharmacological management.
Autorzy:: Lu SY; Division of Cardiology, Department of Internal Medicine, China Medical University Hospital, No. 2, Yuh-Der Road, Taichung, Taiwan.; Graduate Institute of Biomedical Sciences, China Medical University, No. 91, Xueshi Rd., Taichung, Taiwan.
Hsu HY; Department of Pharmacy, China Medical University Hospital, No. 2, Yuder Rd., Taichung, Taiwan.; Graduate Institute of Clinical Pharmacy, College of Medicine, National Taiwan University, No.33, Linsen S. Rd., Taipei, Taiwan.
Hsieh YW; Department of Pharmacy, China Medical University Hospital, No. 2, Yuder Rd., Taichung, Taiwan.; School of Pharmacy, College of Pharmacy, China Medical University, No. 100, Sec. 1, Jingmao Rd., Taichung, Taiwan.
Lu CR; Division of Cardiology, Department of Internal Medicine, China Medical University Hospital, No. 2, Yuh-Der Road, Taichung, Taiwan.
Huang HY; Division of Cardiology, Department of Internal Medicine, China Medical University Hospital, No. 2, Yuh-Der Road, Taichung, Taiwan.
Chang SS; Division of Cardiology, Department of Internal Medicine, China Medical University Hospital, No. 2, Yuh-Der Road, Taichung, Taiwan. .; School of Medicine, College of Medicine, China Medical University, No. 100, Sec. 1, Jingmao Rd., Taichung City, Taiwan. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Mar 28; Vol. 14 (1), pp. 7402. Date of Electronic Publication: 2024 Mar 28.
Typ publikacji:: Journal Article
MeSH Terms:: Hypertension*/drug therapy
Hypertension*/epidemiology
Hypertension*/chemically induced
Gout*/drug therapy
Gout*/complications
Adult ; Humans ; Antihypertensive Agents/therapeutic use ; Sodium Chloride Symporter Inhibitors/therapeutic use ; Retrospective Studies ; Calcium Channel Blockers/therapeutic use ; Thiazides/therapeutic use ; Gout Suppressants/therapeutic use ; Diuretics/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Cardiovascular safety of febuxostat versus allopurinol among the Asian patients with or without gout: A systematic review and meta-analysis.
Autorzy:: Deng JH; Pharmacy Department, Longyan Second Hospital, Longyan, China.
Lai PH; Pharmacy Department, Longyan Second Hospital, Longyan, China.
Xie LS; Pharmacy Department, Longyan Second Hospital, Longyan, China.
Qiu SS; Pharmacy Department, Longyan Second Hospital, Longyan, China.
Qiu DS; Neurology Department, Longyan Second Hospital, Longyan, China.
Zhang JX; Pharmacy Department, Guizhou Provincial People's Hospital, Guiyang, China.; Pokaż więcej
Źródło:: Clinical and translational science [Clin Transl Sci] 2024 Mar; Vol. 17 (3), pp. e13757.
Typ publikacji:: Meta-Analysis; Systematic Review; Journal Article
MeSH Terms:: Hyperuricemia*/complications
Hyperuricemia*/drug therapy
Cardiovascular Diseases*/chemically induced
Cardiovascular Diseases*/epidemiology
Gout*/drug therapy
Humans ; Allopurinol/adverse effects ; Febuxostat/adverse effects ; Gout Suppressants/adverse effects ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Factors for achieving target serum uric acid levels after initiating urate-lowering therapy in patients with gout: results from the ULTRA registry.
Autorzy:: Do H; Division of Rheumatology, Department of Internal Medicine, Kangwon National University School of Medicine, 1 Kangwondaehak-gil, Chuncheon, 24341, South Korea.
Choi HJ; Division of Rheumatology, Department of Internal Medicine, Gil Medical Center, Gachon University College of Medicine, Incheon, South Korea.
Choi B; Division of Rheumatology, Department of Internal Medicine, Seoul Metropolitan Seoul Medical Center, Seoul, South Korea.
Son CN; Division of Rheumatology, Department of Internal Medicine, Eulji University School of Medicine, Uijeongbu, South Korea.
Kim SH; Division of Rheumatology, Department of Internal Medicine, Keimyung University School of Medicine, Daegu, South Korea.
Choi SR; Division of Rheumatology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea.
Kim JH; Division of Rheumatology, Department of Internal Medicine, Chungbuk National University Hospital, Cheongju, South Korea.
Kim MJ; Division of Rheumatology, Department of Internal Medicine, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul, South Korea.
Shin K; Division of Rheumatology, Department of Internal Medicine, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul, South Korea.
Kim HO; Division of Rheumatology, Department of Internal Medicine, Gyeongsang National University School of Medicine, Jinju, South Korea.
Song R; Division of Rheumatology, Department of Internal Medicine, Kyung Hee University, Seoul, South Korea.
Lee SW; Division of Rheumatology, Department of Internal Medicine, Soon Chun Hyang University Hospital, Cheonan, South Korea.
Ahn JK; Division of Rheumatology, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Lee SG; Division of Rheumatology, Department of Internal Medicine, Pusan National University School of Medicine, Pusan National University Hospital, Busan, South Korea.
Lee CH; Division of Rheumatology, Department of Internal Medicine, Wonkwang University School of Medicine, Iksan, South Korea.
Son KM; Division of Rheumatology, Department of Internal Medicine, Hallym University Dongtan Sacred Heart Hospital, Hwaseong-si, Gyeonggi-do, South Korea.
Moon KW; Division of Rheumatology, Department of Internal Medicine, Kangwon National University School of Medicine, 1 Kangwondaehak-gil, Chuncheon, 24341, South Korea. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2023 Nov 22; Vol. 13 (1), pp. 20511. Date of Electronic Publication: 2023 Nov 22.
Typ publikacji:: Journal Article
MeSH Terms:: Uric Acid*
Gout*
Humans ; Male ; Middle Aged ; Female ; Gout Suppressants/therapeutic use ; Antihypertensive Agents/therapeutic use ; Multivariate Analysis

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Cohort study investigating gout flares and management in UK general practice.
Autorzy:: Finnikin S; Institute of Applied Health Research, University of Birmingham, Birmingham, B15 2TT, UK. .
Mallen CD; Primary Care Centre Versus Arthritis, School of Medicine, Keele University, Keele, UK.
Roddy E; Primary Care Centre Versus Arthritis, School of Medicine, Keele University, Keele, UK.; Haywood Academic Rheumatology Centre, Midlands Partnership NHS Foundation Trust, Stoke-On-Trent, UK.; Pokaż więcej
Źródło:: BMC primary care [BMC Prim Care] 2023 Nov 22; Vol. 24 (1), pp. 246. Date of Electronic Publication: 2023 Nov 22.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Gout*/diagnosis
Gout*/drug therapy
Gout*/epidemiology
General Practice*
Humans ; Male ; Uric Acid/therapeutic use ; Gout Suppressants/therapeutic use ; Cohort Studies ; Symptom Flare Up ; United Kingdom/epidemiology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Model-based cost-effectiveness analyses comparing combinations of urate lowering therapy and anti-inflammatory treatment in gout patients.
Autorzy:: van de Laar CJ; Transparency in Healthcare BV, Hengelo, the Netherlands.
Janssen CA; Transparency in Healthcare BV, Hengelo, the Netherlands.; Department of Psychology, Health & Technology, University of Twente, Enschede, The Netherlands.
Janssen M; Department of Rheumatology, VieCuri Medical Center, Venlo, The Netherlands.
Oude Voshaar MAH; Transparency in Healthcare BV, Hengelo, the Netherlands.; Department of Psychology, Health & Technology, University of Twente, Enschede, The Netherlands.
Al MJ; Institute for Medical Technology Assessment, Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, The Netherlands.
van de Laar MAFJ; Transparency in Healthcare BV, Hengelo, the Netherlands.; Department of Psychology, Health & Technology, University of Twente, Enschede, The Netherlands.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2022 Jan 28; Vol. 17 (1), pp. e0261940. Date of Electronic Publication: 2022 Jan 28 (Print Publication: 2022).
Typ publikacji:: Comparative Study; Journal Article
MeSH Terms:: Drug Therapy, Combination*
Gout*/blood
Gout*/drug therapy
Gout*/economics
Gout Suppressants*/economics
Gout Suppressants*/therapeutic use
Models, Economic*
Uric Acid/*blood
Anti-Inflammatory Agents/economics ; Anti-Inflammatory Agents/therapeutic use ; Cost-Benefit Analysis ; Costs and Cost Analysis ; Humans

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Treating gout - can hypouricemia produced by moderate doses of combined oral treatment give early treatment success? Preliminary observations.
Autorzy:: Löffler W; Rheumatologie Nymphenburg, München, Germany.
Fairbanks L; Purine Laboratory, St. Thomas Hospital, London, UK.
Gibson T; Acute Admission Ward, St. Thomas Hospital, London, UK.; Pokaż więcej
Źródło:: Nucleosides, nucleotides & nucleic acids [Nucleosides Nucleotides Nucleic Acids] 2022; Vol. 41 (12), pp. 1267-1278. Date of Electronic Publication: 2022 Mar 08.
Typ publikacji:: Journal Article
MeSH Terms:: Gout Suppressants*/therapeutic use
Gout Suppressants*/adverse effects
Gout*/complications
Gout*/drug therapy
Humans ; Male ; Febuxostat/therapeutic use ; Treatment Outcome ; Uric Acid ; Allopurinol

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Formulation, characterization, optimization, and in-vivo performance of febuxostat self-nano-emulsifying system loaded sublingual films.
Autorzy:: Habib BA; Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Cairo, Egypt.
Abd El-Samiae AS; Department of Pharmaceutics, National Organization for Drug Control and Research (NODCAR), Giza, Egypt.
El-Houssieny BM; Department of Pharmaceutics, National Organization for Drug Control and Research (NODCAR), Giza, Egypt.
Tag R; Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Cairo, Egypt.; Pokaż więcej
Źródło:: Drug delivery [Drug Deliv] 2021 Dec; Vol. 28 (1), pp. 1321-1333.
Typ publikacji:: Journal Article
MeSH Terms:: Drug Carriers/*chemistry
Febuxostat/*pharmacokinetics
Gout Suppressants/*pharmacokinetics
Nanoparticles/*chemistry
Animals ; Area Under Curve ; Chemistry, Pharmaceutical ; Cross-Over Studies ; Drug Liberation ; Drug Stability ; Emulsions ; Febuxostat/administration & dosage ; Gout Suppressants/administration & dosage ; Half-Life ; Particle Size ; Rabbits ; Sheep ; Solubility ; Surface-Active Agents/chemistry

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Network Pharmacology Study on Morus alba L. Leaves: Pivotal Functions of Bioactives on RAS Signaling Pathway and Its Associated Target Proteins against Gout.
Autorzy:: Oh KK; Department of Bio-Health Convergence, College of Biomedical Science, Kangwon National University, Chuncheon 24341, Korea.
Adnan M; Department of Bio-Health Convergence, College of Biomedical Science, Kangwon National University, Chuncheon 24341, Korea.
Cho DH; Department of Bio-Health Convergence, College of Biomedical Science, Kangwon National University, Chuncheon 24341, Korea.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2021 Aug 29; Vol. 22 (17). Date of Electronic Publication: 2021 Aug 29.
Typ publikacji:: Journal Article
MeSH Terms:: Gout Suppressants/*pharmacology
Morus/*chemistry
Plant Leaves/*chemistry
ras Proteins/*metabolism
Animals ; Drug Evaluation, Preclinical ; Gas Chromatography-Mass Spectrometry ; Gout/drug therapy ; Gout/metabolism ; Gout Suppressants/chemistry ; Gout Suppressants/toxicity ; Humans ; Molecular Docking Simulation ; Protein Interaction Maps ; Signal Transduction/drug effects ; gamma-Tocopherol/analysis ; gamma-Tocopherol/pharmacology

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Xanthine Oxidase Inhibitors from Filipendula ulmaria (L.) Maxim. and Their Efficient Detections by HPTLC and HPLC Analyses.
Autorzy:: Gainche M; Clermont Auvergne INP, Université Clermont Auvergne, CNRS, ICCF, F-63000 Clermont-Ferrand, France.
Ogeron C; Université Clermont-Auvergne, INRA, UNH, Unité de Nutrition Humaine, CRNH Auvergne, F-63000 Clermont-Ferrand, France.
Ripoche I; Clermont Auvergne INP, Université Clermont Auvergne, CNRS, ICCF, F-63000 Clermont-Ferrand, France.
Senejoux F; Université Clermont-Auvergne, INRA, UNH, Unité de Nutrition Humaine, CRNH Auvergne, F-63000 Clermont-Ferrand, France.
Cholet J; Université Clermont-Auvergne, INRA, UNH, Unité de Nutrition Humaine, CRNH Auvergne, F-63000 Clermont-Ferrand, France.
Decombat C; Université Clermont-Auvergne, INRA, UNH, Unité de Nutrition Humaine, CRNH Auvergne, F-63000 Clermont-Ferrand, France.
Delort L; Université Clermont-Auvergne, INRA, UNH, Unité de Nutrition Humaine, CRNH Auvergne, F-63000 Clermont-Ferrand, France.
Berthon JY; Greentech, Biopôle Clermont-Limagne, 63360 Saint-Beauzire, France.
Saunier E; Dômes Pharma, 3 Rue André Citroën, 63430 Pont-du-Château, France.
Caldefie Chezet F; Université Clermont-Auvergne, INRA, UNH, Unité de Nutrition Humaine, CRNH Auvergne, F-63000 Clermont-Ferrand, France.
Chalard P; Clermont Auvergne INP, Université Clermont Auvergne, CNRS, ICCF, F-63000 Clermont-Ferrand, France.; Pokaż więcej
Źródło:: Molecules (Basel, Switzerland) [Molecules] 2021 Mar 30; Vol. 26 (7). Date of Electronic Publication: 2021 Mar 30.
Typ publikacji:: Journal Article
MeSH Terms:: Enzyme Inhibitors*/analysis
Enzyme Inhibitors*/chemistry
Gout Suppressants*/analysis
Gout Suppressants*/chemistry
Filipendula/*chemistry
Plant Extracts/*chemistry
Quercetin/*analogs & derivatives
Xanthine Oxidase/*antagonists & inhibitors
Quercetin/analysis ; Quercetin/chemistry

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Explaining the natural course of gout to people living in the tropics.
Autorzy:: Jatuworapruk K; Department of Medicine, Faculty of Medicine, Thammasat University, Pathumthani, Thailand.
Dalbeth N; Department of Medicine, University of Auckland, Auckland, New Zealand.; Pokaż więcej
Źródło:: International journal of rheumatic diseases [Int J Rheum Dis] 2021 Jun; Vol. 24 (6), pp. 858-859. Date of Electronic Publication: 2021 May 24.
Typ publikacji:: Letter
MeSH Terms:: Gout*/blood
Gout*/drug therapy
Gout Suppressants*/therapeutic use
Uric Acid*/blood
Humans

Opinia redakcyjna

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Urate-lowering therapy following a treat-to-target continuation strategy compared to a treat-to-avoid-symptoms discontinuation strategy in gout patients in remission (GO TEST Finale): study protocol of a multicentre pragmatic randomized superiority trial.
Autorzy:: Peeters IR; Department of Rheumatology, Sint Maartenskliniek, Ubbergen, the Netherlands. .; Radboud Institute of Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands. .
den Broeder AA; Department of Rheumatology, Sint Maartenskliniek, Ubbergen, the Netherlands.; Department of Rheumatology, Radboud University Medical Center, Nijmegen, the Netherlands.
Taylor WJ; Department of Medicine, University of Otago Wellington, Newtown, Wellington, New Zealand.
den Broeder N; Department of Rheumatology, Sint Maartenskliniek, Ubbergen, the Netherlands.; Radboud Institute of Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.
Flendrie M; Department of Rheumatology, Sint Maartenskliniek, Ubbergen, the Netherlands.
van Herwaarden N; Department of Rheumatology, Sint Maartenskliniek, Ubbergen, the Netherlands.; Department of Pharmacology, Radboud University Medical Center, Nijmegen, the Netherlands.; Pokaż więcej
Źródło:: Trials [Trials] 2023 Apr 19; Vol. 24 (1), pp. 282. Date of Electronic Publication: 2023 Apr 19.
Typ publikacji:: Clinical Trial Protocol; Journal Article
MeSH Terms:: Gout*/diagnosis
Gout*/drug therapy
Humans ; Gout Suppressants/adverse effects ; Kidney ; Multicenter Studies as Topic ; Randomized Controlled Trials as Topic ; Symptom Flare Up ; Uric Acid ; Pragmatic Clinical Trials as Topic

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Response to "Urate lowering therapy for patients with gout on hemodialysis".
Autorzy:: Alkilany R; Division of Rheumatology, Department of Medicine, MetroHealth Medical Center/Case Western Reserve University, Cleveland, Ohio, USA.
Einstadter D; Center for Health Care Research and Policy, and Department of Internal Medicine, MetroHealth Medical Center/Case Western Reserve University, Cleveland, Ohio, USA.
Antonelli M; Division of Rheumatology, Department of Medicine, MetroHealth Medical Center/Case Western Reserve University, Cleveland, Ohio, USA.; Pokaż więcej
Źródło:: International journal of rheumatic diseases [Int J Rheum Dis] 2023 Mar; Vol. 26 (3), pp. 585. Date of Electronic Publication: 2022 Dec 20.
Typ publikacji:: Letter; Comment
MeSH Terms:: Uric Acid*
Gout*/drug therapy
Humans ; Gout Suppressants/therapeutic use ; Renal Dialysis

Opinia redakcyjna

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Effect of febuxostat on adverse events and mortality in gout in Taiwan: An interrupted time series analysis.
Autorzy:: Tsai PH; Division of Rheumatology, Allergy and Immunology, Department of Internal Medicine, New Taipei Municipal Tucheng Hospital, New Taipei City, Taiwan.
Kuo CF; Division of Rheumatology, Allergy and Immunology, Department of Internal Medicine, Chang Gung Memorial Hospital at Linkou, Taoyuan City, Taiwan.; Department of Medicine, College of Medicine, Chang Gung University, Taoyuan City, Taiwan.; Division of Rheumatology, Orthopaedics and Dermatology, School of Medicine, University of Nottingham, Nottingham, UK.
Liu JR; Department of Public Health, College of Medicine, Chang Gung University, Taoyuan City, Taiwan.
Li PR; Department of Public Health, College of Medicine, Chang Gung University, Taoyuan City, Taiwan.
See LC; Division of Rheumatology, Allergy and Immunology, Department of Internal Medicine, Chang Gung Memorial Hospital at Linkou, Taoyuan City, Taiwan.; Department of Public Health, College of Medicine, Chang Gung University, Taoyuan City, Taiwan.; Biostatistics Core Laboratory, Molecular Medicine Research Center, Chang Gung University, Taoyuan City, Taiwan.; Pokaż więcej
Źródło:: International journal of rheumatic diseases [Int J Rheum Dis] 2023 Mar; Vol. 26 (3), pp. 471-479. Date of Electronic Publication: 2023 Jan 06.
Typ publikacji:: Journal Article
MeSH Terms:: Percutaneous Coronary Intervention*
Gout*/diagnosis
Myocardial Infarction*
Humans ; Febuxostat/therapeutic use ; Gout Suppressants/therapeutic use ; Retrospective Studies ; Taiwan ; Interrupted Time Series Analysis ; Allopurinol/adverse effects

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Cardiovascular risk of urate-lowering drugs: A study using the National Database of Health Insurance Claims and Specific Health Checkups of Japan.
Autorzy:: Sawada S; Office of Medical Informatics and Epidemiology, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.
Kajiyama K; Office of Medical Informatics and Epidemiology, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.
Shida H; Office of Medical Informatics and Epidemiology, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.
Kimura R; Office of Pharmacovigilance I, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.
Nakazato Y; Office of Pharmacovigilance I, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.
Iguchi T; Office of Pharmacovigilance II, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.
Oniyama Y; Office of Pharmacovigilance I, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.; Office of Pharmacovigilance II, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.
Ishiguro C; Office of Medical Informatics and Epidemiology, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.
Uyama Y; Office of Medical Informatics and Epidemiology, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.; Pokaż więcej
Źródło:: Clinical and translational science [Clin Transl Sci] 2023 Feb; Vol. 16 (2), pp. 206-215. Date of Electronic Publication: 2022 Nov 11.
Typ publikacji:: Observational Study; Journal Article
MeSH Terms:: Gout*/drug therapy
Cardiovascular Diseases*/epidemiology
Cardiovascular Diseases*/drug therapy
Humans ; Uric Acid ; Febuxostat ; Allopurinol ; Gout Suppressants/adverse effects ; Benzbromarone/adverse effects ; Japan/epidemiology ; Risk Factors ; Insurance, Health ; Heart Disease Risk Factors ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Hmong microbiome ANd Gout, Obesity, Vitamin C (HMANGO-C): A phase II clinical study protocol.
Autorzy:: Wen YF; Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota, United States of America.
Culhane-Pera KA; Minnesota Community Care, St. Paul, Minnesota, United States of America.; SoLaHmo Partnership for Health and Wellness, Community-University Health Care Center, Minneapolis, Minnesota, United States of America.
Pergament SL; SoLaHmo Partnership for Health and Wellness, Community-University Health Care Center, Minneapolis, Minnesota, United States of America.
Moua Y; SoLaHmo Partnership for Health and Wellness, Community-University Health Care Center, Minneapolis, Minnesota, United States of America.
Vue B; SoLaHmo Partnership for Health and Wellness, Community-University Health Care Center, Minneapolis, Minnesota, United States of America.
Yang T; SoLaHmo Partnership for Health and Wellness, Community-University Health Care Center, Minneapolis, Minnesota, United States of America.
Lo M; Minnesota Community Care, St. Paul, Minnesota, United States of America.
Sun B; Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota, United States of America.
Knights D; Bioinformatics and Computational Biology Program, University of Minnesota, Minneapolis, Minnesota, United States of America.; Biotechnology Institute, University of Minnesota, Minneapolis, Minnesota, United States of America.; Department of Computer Science and Engineering, University of Minnesota, Minneapolis, Minnesota, United States of America.
Straka RJ; Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota, United States of America.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2023 Feb 01; Vol. 18 (2), pp. e0279830. Date of Electronic Publication: 2023 Feb 01 (Print Publication: 2023).
Typ publikacji:: Clinical Trial Protocol; Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
MeSH Terms:: Hyperuricemia*
COVID-19*/complications
Gout*/drug therapy
Gout*/epidemiology
Gout*/genetics
Microbiota*/genetics
Male ; Adult ; Humans ; Uric Acid ; Ascorbic Acid/therapeutic use ; Prospective Studies ; SARS-CoV-2 ; Gout Suppressants/therapeutic use ; Obesity/epidemiology ; Obesity/genetics ; Obesity/complications ; Vitamins/therapeutic use ; Clinical Trials, Phase II as Topic

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Treat-to-Target urate-lowering therapy in primary gout patients: A real-world retrospective study at a dedicated gout clinic in China.
Autorzy:: Bai XS; Department of Endocrinology, Zibo Central Hospital, Shandong, China.; The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.; Department of Endocrinology, Zibo Central Hospital, Shandong, China.
Wang M; The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.; Department of Endocrinology, Zibo Central Hospital, Shandong, China.
Zhao XD; Department of Endocrinology, Zibo Central Hospital, Shandong, China.; Department of Endocrinology, Zibo Central Hospital, Shandong, China.
Cui LL; Shandong Provincial Key Laboratory of Metabolic Diseases and Qingdao Key Laboratory of Gout, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
He YW; Shandong Provincial Key Laboratory of Metabolic Diseases and Qingdao Key Laboratory of Gout, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
Wang C; Shandong Provincial Key Laboratory of Metabolic Diseases and Qingdao Key Laboratory of Gout, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
Li XD; Shandong Provincial Key Laboratory of Metabolic Diseases and Qingdao Key Laboratory of Gout, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
Qu XJ; Department of Endocrinology, People's Hospital of Rongcheng, Weihai, Shandong, China.
Sun MS; Department of Rheumatology and Clinical Immunology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
Li CG; Shandong Provincial Key Laboratory of Metabolic Diseases and Qingdao Key Laboratory of Gout, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.; Department of Endocrinology and Metabolic Diseases, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.; Pokaż więcej
Źródło:: Technology and health care : official journal of the European Society for Engineering and Medicine [Technol Health Care] 2021; Vol. 29 (1), pp. 121-131.
Typ publikacji:: Journal Article
MeSH Terms:: Gout*/drug therapy
Gout Suppressants*/therapeutic use
Uric Acid*
China ; Humans ; Retrospective Studies

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: A nurse-led, rheumatologist-assisted telemedicine intervention for dose escalation of urate-lowering therapy in gout.
Autorzy:: Phang KF; Division of Rheumatology, Department of Medicine, National University Hospital, National University Health System, Singapore.
Santosa A; Division of Rheumatology, Department of Medicine, National University Hospital, National University Health System, Singapore.; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Low BPL; Division of Rheumatology, Department of Medicine, National University Hospital, National University Health System, Singapore.
Tan PSH; Department of Medicine, Department of Medicine, National University Hospital, National University Health System, Singapore.
Khong ZW; Department of Surgery, Singapore General Hospital, Singapore.
Lim AYN; Division of Rheumatology, Department of Medicine, National University Hospital, National University Health System, Singapore.; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Teng GG; Division of Rheumatology, Department of Medicine, National University Hospital, National University Health System, Singapore.; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Tay SH; Division of Rheumatology, Department of Medicine, National University Hospital, National University Health System, Singapore.; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.; Pokaż więcej
Źródło:: International journal of rheumatic diseases [Int J Rheum Dis] 2020 Aug; Vol. 23 (9), pp. 1136-1144. Date of Electronic Publication: 2020 Jun 01.
Typ publikacji:: Journal Article
MeSH Terms:: Nurse's Role*
Rheumatology*
Telemedicine*
Allopurinol/*therapeutic use
Gout/*drug therapy
Gout/*nursing
Gout Suppressants/*therapeutic use
Uric Acid/*blood
Adult ; Aged ; Allopurinol/adverse effects ; Biomarkers/blood ; Down-Regulation ; Female ; Gout/blood ; Gout/diagnosis ; Gout Suppressants/adverse effects ; Humans ; Male ; Middle Aged ; Patient Care Team ; Program Evaluation ; Proof of Concept Study ; Rheumatologists ; Time Factors ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: Blood glucose fluctuations detected by continuous glucose monitoring system in gout patients with normal glucose tolerance and the effect of urate-lowering therapy.
Autorzy:: Mu Z; Department of Endocrinology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Wang J; Department of Cancer Radiotherapy, The Affiliated Hospital of Qingdao University, Qingdao, China.
Wang W; Department of Endocrinology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Lv W; Department of Endocrinology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Chen Y; Department of Endocrinology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Wang F; Department of Endocrinology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Zhao Y; Department of Endocrinology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Dong B; Department of Endocrinology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Wang Y; Department of Endocrinology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Wang Z; Department of Endocrinology, The Affiliated Hospital of Qingdao University, Qingdao, China.; Pokaż więcej
Źródło:: International journal of rheumatic diseases [Int J Rheum Dis] 2020 Aug; Vol. 23 (9), pp. 1145-1151. Date of Electronic Publication: 2020 Jun 01.
Typ publikacji:: Journal Article
MeSH Terms:: Blood Glucose Self-Monitoring*
Allopurinol/*therapeutic use
Blood Glucose/*drug effects
Gout/*drug therapy
Gout Suppressants/*therapeutic use
Hyperuricemia/*drug therapy
Uric Acid/*blood
Adult ; Aged ; Allopurinol/adverse effects ; Biomarkers/blood ; Blood Glucose/metabolism ; Down-Regulation ; Female ; Gout/blood ; Gout/diagnosis ; Gout Suppressants/adverse effects ; Humans ; Hyperuricemia/blood ; Hyperuricemia/diagnosis ; Insulin Resistance ; Male ; Middle Aged ; Predictive Value of Tests ; Time Factors ; Treatment Outcome ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: Development of an optimized febuxostat self-nanoemulsified loaded transdermal film: in-vitro, ex-vivo and in-vivo evaluation.
Autorzy:: Alhakamy NA; Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.
Fahmy UA; Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.
Ahmed OAA; Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.; Department of Pharmaceutics & Industrial Pharmacy, Faculty of Pharmacy, Minia University, Minia, Egypt.
Almohammadi EA; Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.
Alotaibi SA; Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.
Aljohani RA; Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.
Alharbi WS; Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.
Alfaleh MA; Department of Natural Products and Alternative Medicine, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.
Alfaifi MY; Biology Department, Faculty of Science, King Khalid University, Abha, Saudi Arabia.; Pokaż więcej
Źródło:: Pharmaceutical development and technology [Pharm Dev Technol] 2020 Mar; Vol. 25 (3), pp. 326-331. Date of Electronic Publication: 2019 Dec 17.
Typ publikacji:: Journal Article
MeSH Terms:: Drug Delivery Systems*
Nanostructures*
Febuxostat/*administration & dosage
Gout Suppressants/*administration & dosage
Administration, Cutaneous ; Animals ; Biological Availability ; Emulsions ; Febuxostat/chemistry ; Febuxostat/pharmacokinetics ; Gout Suppressants/chemistry ; Gout Suppressants/pharmacokinetics ; Male ; Particle Size ; Rats ; Rats, Wistar ; Skin Absorption ; Solubility ; Surface-Active Agents/chemistry

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: Letter to the editor regarding "urate-lowering therapy for patients with gout on hemodialysis".
Autorzy:: Tsai YS; School of Medicine, Chung Shan Medical University, Taichung, Taiwan.
Lee YH; Department of Orthopedics, Cishan Hospital, Ministry of Health and Welfare, Kaohsiung, Taiwan.; Institute of Medical Science and Technology, National Sun Yat-sen University, Kaohsiung, Taiwan.; Department of Senior Services Industry Management, Minghsin University of Science and Technology, Hsinchu, Taiwan.; Department of Recreation and Sport Management, Shu-Te University, Kaohsiung, Taiwan.
Ko MY; Division of Gastroenterology and Hepatology, Changhua Christian Hospital, Changhua, Taiwan.; Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.; Pokaż więcej
Źródło:: International journal of rheumatic diseases [Int J Rheum Dis] 2023 Jan; Vol. 26 (1), pp. 177-178. Date of Electronic Publication: 2022 Oct 17.
Typ publikacji:: Letter; Comment
MeSH Terms:: Uric Acid*
Gout*/diagnosis
Gout*/drug therapy
Humans ; Gout Suppressants/adverse effects ; Renal Dialysis/adverse effects

Opinia redakcyjna

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Gout Suppressants"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język

Rok publikacji